scholarly article | Q13442814 |
P50 | author | Brandon A. Gaudiano | Q40431118 |
Lauren M. Weinstock | Q47826020 | ||
P2093 | author name string | Ivan W Miller | |
Katherine Tezanos | |||
Gary Epstein-Lubow | |||
Cintly E Celis-Dehoyos | |||
P2860 | cites work | Effectiveness of adjunctive antidepressant treatment for bipolar depression | Q28295408 |
The use of administrative data to assess quality of care for bipolar disorder in a large staff model HMO. | Q30587195 | ||
The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study | Q33850634 | ||
Differential item functioning of DSM-IV depressive symptoms in individuals with a history of mania versus those without: an item response theory analysis | Q33964625 | ||
Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects?: a cross-sectional study | Q33972014 | ||
DSM-IV depressive symptom expression among individuals with a history of hypomania: a comparison to those with or without a history of mania | Q34014534 | ||
Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome | Q34034971 | ||
National trends in psychotropic medication polypharmacy in office-based psychiatry | Q34090959 | ||
Correlates of medication adherence among patients with bipolar disorder: results of the bipolar evaluation of satisfaction and tolerability (BEST) study: a nationwide cross-sectional survey | Q34516230 | ||
Psychiatric and medical comorbidities of bipolar disorder | Q36021272 | ||
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies | Q36161335 | ||
Polytherapy in bipolar disorder | Q36361982 | ||
Medical risk in patients with bipolar disorder and schizophrenia. | Q36590638 | ||
Disability and its treatment in bipolar disorder patients | Q36772962 | ||
Improving treatment adherence in bipolar disorder: a review of current psychosocial treatment efficacy and recommendations for future treatment development | Q36951439 | ||
The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. | Q37581138 | ||
Bipolar disorder and ADHD: Clinical concerns. | Q37601923 | ||
Polypharmacy and bipolar disorder: what's personality got to do with it? | Q38143335 | ||
Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD. | Q38383710 | ||
Course of illness and maintenance treatments for patients with bipolar disorder | Q40579988 | ||
Polypharmacy in bipolar I disorder. | Q41306525 | ||
Psychopharmacology: rational and irrational polypharmacy | Q43463430 | ||
Trends in the treatment of bipolar disorder by outpatient psychiatrists | Q44013090 | ||
Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project | Q44271371 | ||
Treatment adherence and illness insight in veterans with bipolar disorder | Q45332060 | ||
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. | Q45484599 | ||
A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. | Q45931601 | ||
Psychosocial disability and work role function compared across the long-term course of bipolar I, bipolar II and unipolar major depressive disorders | Q46265953 | ||
The long-term natural history of the weekly symptomatic status of bipolar I disorder | Q46317822 | ||
Nosology, diagnostic challenges, and unmet needs in managing bipolar disorder | Q46752259 | ||
Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder | Q46756223 | ||
Polypharmacy: correlations with sex, age and drug regimen. A prescription database study. | Q50873662 | ||
Help-seeking behaviour in men and women with common mental health problems: cross-sectional study. | Q51931619 | ||
Long-term symptomatic status of bipolar I vs. bipolar II disorders. | Q51947488 | ||
Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. | Q51948101 | ||
Psychotropic drug prescription patterns among patients with bipolar I disorder. | Q52066927 | ||
Medication prescribing patterns for patients with bipolar I disorder in hospital settings: adherence to published practice guidelines | Q74502624 | ||
Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders | Q79535158 | ||
The increasing medical burden in bipolar disorder | Q81782161 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | bipolar disorder | Q131755 |
P304 | page(s) | 24-30 | |
P577 | publication date | 2014-02-01 | |
P1433 | published in | Psychiatry Research | Q15750888 |
P1476 | title | Medication burden in bipolar disorder: a chart review of patients at psychiatric hospital admission | |
P478 | volume | 216 |
Q35940930 | Adjunctive psychosocial intervention following Hospital discharge for Patients with bipolar disorder and comorbid substance use: A pilot randomized controlled trial |
Q28597251 | Applications of time-series analysis to mood fluctuations in bipolar disorder to promote treatment innovation: a case series. |
Q89665749 | Complex Combination Pharmacotherapy for Bipolar Disorder: Knowing When Less Is More or More Is Better |
Q89154822 | Comprehensive comparison of monotherapies for psychiatric hospitalization risk in bipolar disorders |
Q36471096 | Demographic and clinical characteristics associated with comorbid cannabis use disorders (CUDs) in hospitalized patients with bipolar I disorder |
Q37514635 | Dosing patterns and medication adherence in bipolar disorder patients treated with lurasidone: a US retrospective claims database analysis |
Q38364032 | Drugs under early investigation for the treatment of bipolar disorder. |
Q41889345 | Efficacy of repetitive transcranial magnetic stimulation with quetiapine in treating bipolar II depression: a randomized, double-blinded, control study |
Q37424330 | Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder |
Q89044428 | Identifying clinical net benefit of psychotropic medication use with latent variable techniques: Evidence from Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) |
Q90109696 | Predictors of 30-day rehospitalization in a sample of hospitalized patients with Bipolar I disorder |
Q55688955 | Prevalence and Associated Features of Anxiety Disorder Comorbidity in Bipolar Disorder: A Meta-Analysis and Meta-Regression Study. |
Q26751363 | Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review |
Q88527763 | Regularity of self-reported daily dosage of mood stabilizers and antipsychotics in patients with bipolar disorder |
Q33606886 | Self-poisoning suicide deaths in people with bipolar disorder: characterizing a subgroup and identifying treatment patterns. |
Q26766633 | The Neurobiology of Bipolar Disorder: An Integrated Approach |
Q38753620 | Valued Living and Its Relationship to Medication Adherence in Patients with Bipolar and Comorbid Substance Use Disorders |